Cargando…

Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report

Detalles Bibliográficos
Autores principales:	Borghesi, Luca, Viaggi, Valentina, Franzetti, Marco, Montoli, Matteo, Mauri, Carola, Moioli, Giovanni, Benvenuti, Mauro Roberto, Piconi, Stefania, Luzzaro, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455353/ https://www.ncbi.nlm.nih.gov/pubmed/34562658 http://dx.doi.org/10.1016/j.jgar.2021.09.005

Ejemplares similares

Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa
por: Brookfield, Charlotte, et al.
Publicado: (2023)

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
por: Kufel, Wesley D., et al.
Publicado: (2020)

Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa
por: Sadek, Mustafa, et al.
Publicado: (2022)

Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis
por: Simner, Patricia J., et al.
Publicado: (2022)

Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa
por: Chavda, A, et al.
Publicado: (2021)

Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
por: Simner, Patricia J, et al.
Publicado: (2021)

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis
por: Romanowski, Eric G., et al.
Publicado: (2023)

Pleural Infection and Empyema
por: Kwon, Yong Soo
Publicado: (2014)

P44 Nosocomial neurosurgical meningitis due to XDR Pseudomonas aeruginosa: clinical experience with cefiderocol
por: Stevenson, D. R., et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

648. Cefiderocol as Rescue Therapy for Pseudomonas aeruginosa and Other Difficult-To-Treat Gram-Negative Infections
por: Chou, Andrew, et al.
Publicado: (2022)

Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
por: Satlin, Michael J., et al.
Publicado: (2023)

2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

The Treatment of Acute Pleural Empyema
por: Stuart, W. J.
Publicado: (1937)

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa
por: Ito, Akinobu, et al.
Publicado: (2016)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

P24 Cefiderocol activity against a multidrug-resistant (MDR) strain of Pseudomonas aeruginosa: a case report
por: Lim,, Felicia H., et al.
Publicado: (2022)

Massive ventilator-associated pleural empyema
por: Jud, Philipp, et al.
Publicado: (2019)

Pleural Effusion/Empyema With Mycobacterium kansasii
por: Luttmann, Kelly F, et al.
Publicado: (2022)

Pleural empyema caused by Actinomyces turicensis
por: Agrafiotis, Apostolos C., et al.
Publicado: (2021)

New therapy of pleural empyema by deoxyribonuclease
por: Kacprzak, Grzegorz, et al.
Publicado: (2013)

Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012)

Pleural empyema secondary to nephropleural fistula in complicated pyonephrosis
por: Tamburrini, Stefania, et al.
Publicado: (2021)

The effect of Cyclic-di-GMP on biofilm formation by Pseudomonas aeruginosa in a novel empyema model
por: Zhang, Li, et al.
Publicado: (2020)

Pleural epithelioid hemangioendothelioma mimicking pleural empyema: A case report
por: Fjaellegaard, Katrine, et al.
Publicado: (2020)

Clinical Cure of a Difficult-to-Treat Resistant Pseudomonas aeruginosa Ventriculitis Using Cefiderocol: A Case Report and Literature Review
por: Marcelo, Cristina, et al.
Publicado: (2022)

Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
por: Ito, Akinobu, et al.
Publicado: (2019)

Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa
por: Edgeworth, Jonathan D, et al.
Publicado: (2019)

Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
por: Ito, Akinobu, et al.
Publicado: (2018)

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia
por: Delgado-Valverde, Mercedes, et al.
Publicado: (2020)

In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors
por: Shields, Ryan K, et al.
Publicado: (2023)

Surgical treatment of pleural empyema in Coronavirus disease 19 patients: the Southern Switzerland experience
por: Tessitore, Adele, et al.
Publicado: (2020)

DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models
por: Deng, Wusheng, et al.
Publicado: (2022)

Outcome and non-chemotherapeutic treatment in pleural empyema
por: Nielsen, Jannie, et al.
Publicado: (2009)

Pleural Empyema due to Group D Salmonella
por: Kam, Jennifer C., et al.
Publicado: (2012)

Surgical management of pleural empyema in the very elderly
por: Schweigert, M, et al.
Publicado: (2012)

Depression is associated with subsequent risk of pleural empyema
por: Shen, Yi-Chen, et al.
Publicado: (2020)

Rheumatoid arthritis increases the risk of pleural empyema
por: Liao, Kuang-Ming, et al.
Publicado: (2020)

Empyema of Pleural Cavity—Report of Four Cases
por: Alexander, R. J.
Publicado: (1900)

Cannot write session to /tmp/vufind_sessions/sess_proc9e3q0agrieo9bck4asplul